Alzheimer's disease: treatment research finds new targets.
Hodes
R J
RJ
National Institute on Aging, Office of the Director, Bethesda, MD 20892.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics; D016229:Amyloid beta-Peptides / Q000378:metabolism; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism; D001521:Behavior Therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009316:National Institutes of Health (U.S.); D012106:Research; D014481:United States
D016229:Amyloid beta-Peptides; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D002800:Cholinesterase Inhibitors